New Look Eyewear Inc. Closes $10 Million Private Placement

By Staff
Wednesday, August 20, 2014 12:23 AM MONTREAL— New Look Eyewear Inc. (BCI) said yesterday that it has completed its previously announced "bought deal" private placement subscription receipt financing for aggregate gross proceeds of $10 million, in connection with the offering to fund the recently-announced acquisition of certain assets and business of the Grieche & Scaff banner here, as reported earlier this month by VMail.

InSite Vision Inc. Reports Q2 2014 Results

By Staff
Friday, August 15, 2014 12:23 AM ALAMEDA, Calif.— InSite Vision Incorporated (OTCBB:INSV) has reported financial results for the second quarter ended June 30, 2014.

Allergan and Valeant Pharmaceuticals Receive FTC Second Request Under Hart-Scott-Rodino Act

By Staff
Wednesday, August 13, 2014 12:16 AM IRVINE, Calif. And Quebec— Allergan, Inc. (NYSE: AGN) and Valeant Pharmaceuticals (NYSE:VRX)  have both received a request for additional information (a "Second Request") under the Hart-Scott-Rodino Act from the U.S. Federal Trade Commission in connection with Valeant’s unsolicited acquisition proposal of Allergan.

Spy Reports First Half and Q2 2014 Results

By Staff
Friday, August 08, 2014 12:26 AM CARLSBAD, Calif.— SPY Inc. (OTCBB: XSPY) has announced its financial results for the second quarter and first six months ended June 30, 2014.

New Look Eyewear Reports Record Sales for Q2 and First Half

By Staff
Friday, August 08, 2014 12:23 AM MONTREAL— New Look Eyewear Inc. (TSX: BCI) announced its results for the second quarter, for the period ending June 28, 2014 and reported record revenues of $35.1 million for the period.

Allergan Sues Valeant and Pershing Square

By Staff
Friday, August 01, 2014 2:00 PM IRVINE, Calif.— Valeant and Pershing Square Capital Management’s $51 billion hostile takeover bid for Allergan is taking a new turn with Allergan filing a lawsuit alleging that Valeant, Pershing Square and its principal, William A. Ackman, violated federal laws prohibiting insider trading.

Safilo Approves Q2 and First Half 2014 Financial Results

By Staff
Friday, August 01, 2014 12:23 AM PADUA—The Board of Directors of Safilo Group S.p.A. (SFL:MI) has approved today the results of the second quarter and first half of 2014, ended June 30.

Valeant Pharmaceuticals Reports Revenue Increase for Q2

By Staff
Friday, August 01, 2014 12:21 AM LAVAL, Quebec – Valeant Pharmaceuticals, Inc. (NYSE/TSX:VRX) reported its total revenue for the second fiscal quarter was $2.0 billion, up 86 percent compared to the second quarter of 2013, driven by strong growth in almost all of its businesses, the company said.

SynergEyes Raises $12 Million in New Financing

By Staff
Friday, August 01, 2014 12:20 AM CARLSBAD, Calif. – SynergEyes, Inc., manufacturer and marketer of the Duette and UltraHealth families of contact lenses, announced it has raised $12 million to accelerate expansion of its contact lenses for patients with astigmatism, presbyopia and irregular corneas.

Luxottica Group Q2 2014 Results Show Continuing Growth in North America, Emerging Markets and Europe

By Staff
Friday, July 25, 2014 12:26 AM
MILAN— Luxottica Group (NYSE: LUX) reported accelerated net sales growth in the second quarter ending June 30, 2014 to €2,060 million, up 7 percent at constant exchange rates when compared to the €2,018 million generated during the same period of 2013, according to the company’s financial results released yesterday.

Allergan Sales Rose Nearly 16 Percent in Second Quarter

By Staff
Wednesday, July 23, 2014 12:26 AM IRVINE, Calif.— Allergan (NYSE: AGN) reported $1,827.3 million total product net sales for the quarter ended June 30, 2014, a 15.9 percent compared to total product net sales in the second quarter of 2013.

MacKeyser/American Optical Services Makes Second Bankruptcy Court Appearance, Schedules Auction of Certain Assets

By Staff
Monday, July 21, 2014 12:36 AM WILMINGTON, Del.—The Chapter 11 bankruptcy proceedings for MacKeyser Holdings, LLC and its subsidiaries, which include American Optical Services (AOS) and a number of other optical businesses the company had acquired prior to its bankruptcy, proceeded last week with the company’s second court appearance on July 16.

Allergan Announces Q2 Conference Call

By Staff
Monday, July 21, 2014 12:24 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) will host a conference call to discuss the company’s second quarter 2014 results today beginning at 7:30 a.m. Pacific Time (10:30 am Eastern Time) with David Pyott, chairman and CEO, and Jeff Edwards, executive vice president, finance and business development and chief financial officer.

New Customers Drive Optos Sales Growth in 2014 Fiscal Year Third Quarter

By Staff
Friday, July 18, 2014 12:24 AM LONDON—Retinal imaging company, Optos PLC (LSE: OPTS) announced yesterday that its revenues for the company’s third quarter (the three-month period ending June 30, 2014) of the company’s 2014 fiscal year were $42 million, 5 percent higher than the $40.1 million generated during the comparable period last year.

Allergan Files Investor Presentation Claiming Valeant’s Business Model is 'Unsustainable'

By Staff
Wednesday, July 16, 2014 12:27 AM IRVINE, Calif.— Allergan, Inc. (NYSE: AGN) has filed an investor presentation with the Securities and Exchange Commission that raises further concerns about what it characterizes as “potential business risks and issues” related to a proposed purchase by Valeant Pharmaceuticals International (NYSE/TSX: VRX).
Loading...